Processa Pharmaceuticals, Inc. - Common Stock (PCSA)
0.2750
-0.0451 (-14.09%)
NASDAQ · Last Trade: Jun 24th, 12:54 AM EDT
Detailed Quote
Previous Close
0.3201
Open
0.2617
Bid
0.2661
Ask
0.2668
Day's Range
0.2550 - 0.3096
52 Week Range
0.1500 - 3.100
Volume
16,560,445
Market Cap
3.27M
PE Ratio (TTM)
-0.0893
EPS (TTM)
-3.1
Dividend & Yield
N/A (N/A)
1 Month Average Volume
47,490,834
Chart
About Processa Pharmaceuticals, Inc. - Common Stock (PCSA)
Processa Pharmaceuticals Inc. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for patients with unmet medical needs. The company primarily concentrates on advancing treatments for various cancer types and gastrointestinal disorders by utilizing its proprietary drug candidates. Through rigorous research and clinical trials, Processa aims to improve patient outcomes and enhance the quality of life for those affected by serious health conditions. Its strategic approach includes leveraging repurposed existing therapies as well as developing novel compounds, highlighting its commitment to addressing significant healthcare challenges. Read More
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
Peraso Inc. (NASDAQ: PRSO), a leader in millimeter wave (mmWave) wireless technology, has announced the initial production shipments of its next-gen 60 GHz wireless communication platform, marking a major step into the global tactical communications and battlefield safety market.
Processa Pharmaceuticals' stock is surging after licensing a gastroparesis drug to Intact Therapeutics. The deal promises milestone payments and royalties for Processa.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
